Enter your login e-mail to the account
Search
- The relationship between psychotic experiences and conspiratorial ideation in a non-clinical population − a pilot study
Mgr. Natália Čavojská, Prof. MUDr. Ján Pečeňák, PhD., Doc. PhDr. Michal Hajdúk, PhD.
(1/2023, Original articles ) - The mobile technologies in a treatment of mental disorders: Project IMMERSE
Mgr. Adam Kurilla, Mgr. Daniel Dančík, PhD., Mgr. Natália Čavojská, doc. MUDr. Ľubomíra Izáková, PhD., Prof. MUDr. Ján Pečeňák, CSc., Doc. PhDr. Michal Hajdúk, PhD., prof. Mgr. Anton Heretik, PhD.
(4/2022, Review articles ) - Mám článok!
Prof. MUDr. Ján Pečeňák, CSc.
(2/2022, Editorial ) - Stručná správa o „korone“ z psychiatrie
Prof. MUDr. Ján Pečeňák, CSc., MUDr. Lucia Žlnayová, PhD.
(3/2020, Information & comments ) - Prevalence of psychotic symptoms in the general population – correlates with schizophrenia risk factors
PhDr. Michal Hajdúk, PhD., Mgr. Daniel Dančík, BSc., Mgr. Jakub Januška, Mgr. Alexandra Straková, Prof. MUDr. Ján Pečeňák, PhD.
(2/2020, Review articles ) - Profile of atypical antipsychotic lurasidone
Prof. MUDr. Ján Pečeňák, CSc.
(2/2020, Review articles ) - Čas korony
Prof. MUDr. Ján Pečeňák, CSc.
(1/2020, Editorial ) - Subjektívna funkčnosť a spokojnosť so životom u pacientov s poruchami z okruhu schizofrenického spektra
MUDr. Dana Krajčovičová, PhD., Mgr. Miroslava Zimányiová, PhD., PhDr. Michal Hajdúk, PhD., doc. MUDr. Viera Kořínková, CSc., doc. Mgr. Anton Heretik, PhD., Prof. MUDr. Ján Pečeňák, CSc.
(3/2018, Original articles & case reports ) - Paliperidone palmitate for once a three month application. Basic characteristics with emphasis on clinical use
Prof. MUDr. Ján Pečeňák, CSc.
(1/2017, Psychopharmacology ) - Vortioxetine – the antidepressant with multimodal activity
doc. MUDr. Ján Pečeňák, CSc.
(1/2015, Psychopharmacology ) - DSM-5 – the new edition of classification of mental disorders of American Psychiatric Association
doc. MUDr. Ján Pečeňák, CSc.
(1/2014, Main topic ) - Paliperidone palmitate – long-acting injectable antipsychotic. Basic characteristics with emphasis on clinical use
doc. MUDr. Ján Pečeňák, CSc.
(2/2012, Drugs & drug classes ) - Úvodné slovo
doc. MUDr. Ján Pečeňák, CSc.
(1/2012, Editorial ) - Agomelatine – first results from trial VALID in Slovakia
prof. MUDr. Vladimír Novotný, CSc., doc. MUDr. Ján Pečeňák, CSc.
(1/2011, Original articles & case reports ) - Mechanism of effect of agomelatine – the innovative approach to the treatment of depression
doc. MUDr. Ján Pečeňák, CSc.
(6/2009, Drugs & drug classes ) - Concepts of evaluation of the long-term treatment of schizophrenia
doc. MUDr. Ján Pečeňák, CSc., MUDr. Mgr. Helena Aziri
(5/2009, Review articles ) - Development of antidepressants: from imipramine to agomelatine
doc. MUDr. Ján Pečeňák, CSc.
(3/2009, Drugs & drug classes ) - SECOND GENERATION ANTIPSYCHOTICS IN RELAPSE PREVENTION OF SCHIZOPHRENIA – THE RECENT FINDINGS FROM SELECTED DOUBLE-BLIND, RANDOMIZED TRIALS
MUDr. Ján Pečeňák, CSc.
(1/2006, Review articles )
- Vortioxetine – the antidepressant with multimodal activity
doc. MUDr. Ján Pečeňák, CSc.
(3/2015, Pharmacotherapy ) - Treatment of delirium
doc. MUDr. Ján Pečeňák, CSc.
(5/2011, Main topic )